two dead ago success transfer antigen present cell apc vivo demons result induce primary adapt immune response due good biocompat plasmid dna costeffici product long shelf life mani research aim develop vaccines immunotherapeut strategy treatment infect cancer also autoimmune disease allergic review aim summary current knowledge cours action vaccine factor response poor immunogen human far import optic step improv office comprise introduce dnacomplex nanocarri prevent extracellular degrade enable target enhance endolysosom escape attach virusderiv nuclear local sequence facility entry improv vaccine design include use apcspecif promoter transcript arrange multiple codeliveri molecular adj tower circuit potent inhibitor effect vector backbone clinic may require combine employ parapet combine admit drug 